BridgeMD
New treatment option for Primary Progressive Aphasia
Official title Cognitive Reserve and Response to Speech-Language Intervention in Bilingual Speakers With Primary Progressive Aphasia
ClinicalTrials.gov ID: NCT05741853
What this study is testing
- What it's testing
- Difficulties with speech and language are the first and most notable symptoms of primary progressive aphasia (PPA). While there is evidence that demonstrates positive effects of speech-language treatment for individuals with PPA who only speak one language (monolinguals), there is a significant need for investigating the effects of treatment that is optimized for bilingual speakers with PPA.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 and older. Healthy volunteers may be eligible.
You may be able to join if
- Meets diagnostic criteria for Primary Progressive Aphasia (PPA; Gorno-Tempini et al., 2011)
- Bilingual in Spanish and Catalan or bilingual in Spanish and English
- Different proficiency levels across languages are expected, any prior experience in both languages is acceptable
- Intervention study: Score of 15 or higher on the Mini-Mental State Examination
- Note that this project will also recruit individuals to participate in assessment only, for these individuals the following applies: Score of 10 or...
You likely can't join if
- Other central nervous system or medical diagnosis that can cause symptoms
- Other psychiatric diagnosis that can cause symptoms
- Significant, uncorrected visual or hearing impairment that would interfere with participation
- Prominent initial non-speech-language impairments (cognitive, behavioral, motoric)
- Intervention Study: Score of less than 15 on the Mini-Mental State Examination
- Note that this project will also recruit individuals to participate in assessment only, for these individuals the following inclusion criteria...
The study team makes the final eligibility decision.
Where it's taking place
- Austin, Texas, United States
- Barcelona, Barcelona, Spain
- Barcelona, Spain
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 40 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Austin, Texas, United States; Barcelona, Barcelona, Spain; Barcelona, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.